Back Dictionary Export CSV
Filter: Clear
MERGED_REGIMEN_ID MERGED_TUMOUR_ID HEIGHT_AT_START_OF_REGIMEN WEIGHT_AT_START_OF_REGIMEN INTENT_OF_TREATMENT DATE_DECISION_TO_TREAT START_DATE_OF_REGIMEN MAPPED_REGIMEN CLINICAL_TRIAL CHEMO_RADIATION MERGED_PATIENT_ID BENCHMARK_GROUP
210030504 210010386 1.82 97 Palliative (P) 2015-01-11 2015-01-26 Temozolomide + RT 02 Y 210022224 TEMOZOLOMIDE + RT
210030505 210010388 1.63 90 Disease modification (D) null 2017-10-27 Temozolomide + RT N N 210022230 TEMOZOLOMIDE + RT
210030506 210020719 null 150 Curative (C) 2019-01-27 2019-02-12 Temozolomide + RT null Y 210022299 TEMOZOLOMIDE + RT
210030507 210010403 null 67.6 Adjuvant (A) null 2015-04-12 Temozolomide + RT N null 210022448 TEMOZOLOMIDE + RT
210030508 210020732 null null Disease modification (D) 2015-12-16 2015-12-30 Temozolomide + RT N Y 210022614 TEMOZOLOMIDE + RT
210030509 210010418 null 94.9 Unknown (U) null 2017-02-15 Temozolomide + RT null N 210022620 TEMOZOLOMIDE + RT
210030510 210030960 1.87 null Curative (C) 2019-03-07 2019-03-07 Trial Unspecified N N 210022624 TRIAL
210030511 210010428 1.61 73.8 Curative (C) 2019-07-22 2019-08-05 Trial Unspecified Y null 210022728 TRIAL
210030512 210010444 null 49.6 Curative (C) 2015-07-19 2015-07-19 Trial Unspecified Y N 210022961 TRIAL
210030513 210010446 1.29 96.3 null 2014-07-16 2014-08-23 Temozolomide + RT N null 210022962 TEMOZOLOMIDE + RT
210030514 210010449 1.82 67.05 Palliative (P) null 2017-11-03 Temozolomide + RT N N 210023044 TEMOZOLOMIDE + RT
210030515 210020761 null 79.8 Adjuvant (A) 2016-10-29 2016-10-30 Trial Unspecified N null 210023048 TRIAL
210030516 210010455 1.7 72.6 Curative (C) 2017-06-07 2017-07-14 Trial Unspecified 01 Y 210023081 TRIAL
210030517 210010462 1.6 83.1 Curative (C) 2015-11-20 2016-03-25 CNS HGG HERBY Bevacizumab Y null 210023222 TRIAL
210030518 210020775 1.65 82 Curative (C) 2015-04-13 2015-06-07 Trial Unspecified N N 210023251 TRIAL
210030519 210027162 1.67 80 Palliative (P) 2018-01-13 2018-03-16 Temozolomide + RT N null 210023274 TEMOZOLOMIDE + RT
210030520 210010481 0 76 Curative (C) 2018-09-02 2018-09-17 Temozolomide + RT N Y 210023331 TEMOZOLOMIDE + RT
210030521 210010484 1.69 67.2 Curative (C) 2018-02-04 2018-02-24 Temozolomide + RT 02 Y 210023346 TEMOZOLOMIDE + RT
210030522 210010492 1.7 76.2 null 2017-10-02 2017-10-30 Temozolomide + RT N Y 210023423 TEMOZOLOMIDE + RT
210030523 210010496 1.8 null Curative (C) null 2015-07-14 Trial Unspecified N N 210023453 TRIAL
210030524 210010498 0 91.2 Adjuvant (A) 2015-01-07 2015-01-25 Trial Unspecified 01 N 210023473 TRIAL
210030525 210010520 1.7 72.9 Palliative (P) null 2014-02-13 Trial Unspecified 01 N 210023722 TRIAL
210030526 210034954 1.88 67.2 Adjuvant (A) 2018-11-16 2019-01-01 Temozolomide + RT N Y 210023729 TEMOZOLOMIDE + RT
210030527 210027178 1.8 null Curative (C) 2018-05-01 2018-07-10 Temozolomide + RT N Y 210023738 TEMOZOLOMIDE + RT
210030528 210010525 1.62 15.7 Adjuvant (A) 2014-11-25 2014-11-25 Trial Unspecified 01 null 210023790 TRIAL
210030529 210010528 null null Unknown (U) 2016-02-05 2016-02-15 Trial Unspecified null N 210023841 TRIAL
210030530 210010531 null 41 Curative (C) 2016-12-27 2017-01-14 Temozolomide + RT null Y 210023859 TEMOZOLOMIDE + RT
210030531 210010531 1.89 85 Curative (C) 2016-12-19 2018-10-21 Trial Unspecified N Y 210023859 TRIAL
210030532 210010535 1.69 78 Palliative (P) 2015-11-10 2015-12-10 Temozolomide + RT N N 210023922 TEMOZOLOMIDE + RT
210030533 210010539 null 65.4 Curative (C) 2016-10-10 2016-12-13 Temozolomide + RT N Y 210023954 TEMOZOLOMIDE + RT
210030534 210010539 1.58 84.1 Curative (C) 2015-10-19 2015-11-04 ESPHALL TRIAL N null 210023954 TRIAL
210030535 210020831 null 65.4 Curative (C) null 2019-09-17 Temozolomide + RT N null 210023998 TEMOZOLOMIDE + RT
210030536 210010546 1.62 90 null null 2016-05-30 Temozolomide + RT N Y 210024052 TEMOZOLOMIDE + RT
210030537 210020836 1.5 73 Curative (C) 2017-03-05 2017-03-20 Temozolomide + RT N Y 210024080 TEMOZOLOMIDE + RT
210030538 210010568 1.6 null Curative (C) 2019-04-16 2019-05-14 Temozolomide + RT N Y 210024283 TEMOZOLOMIDE + RT
210030539 210010574 1.87 null Curative (C) 2017-03-07 2017-03-07 Trial Unspecified N Y 210024338 TRIAL
210030540 210010577 1.63 73.3 Curative (C) null 2018-12-15 Temozolomide + RT 2 Y 210024422 TEMOZOLOMIDE + RT
210030541 210010587 1.64 null Curative (C) 2013-11-14 2014-11-04 ESPHALL TRIAL N N 210024534 TRIAL
210030542 210010591 1.64 52.7 Disease modification (D) null 2017-03-05 Temozolomide + RT N null 210024563 TEMOZOLOMIDE + RT
210030543 210020873 1.57 104.5 Curative (C) null 2015-11-22 Temozolomide + RT Y null 210024579 TEMOZOLOMIDE + RT
210030545 210010608 0 91.9 Curative (C) 2014-12-11 2015-04-29 Trial Unspecified 01 N 210024774 TRIAL
210030546 210010613 1.7 48 Curative (C) 2017-02-26 2017-05-10 Temozolomide + RT 02 N 210024800 TEMOZOLOMIDE + RT
210030547 210010615 1.61 53.4 Palliative (P) 2015-07-09 2015-07-16 ESPHALL TRIAL 1 null 210024818 TRIAL
210030548 210027216 1.55 76 Curative (C) 2015-06-15 2015-07-16 Temozolomide + RT N null 210024926 TEMOZOLOMIDE + RT
210030549 210020895 1.7 null Curative (C) 2015-12-14 2016-02-18 Temozolomide + RT N N 210024977 TEMOZOLOMIDE + RT
210030550 210010629 1.76 85 Curative (C) 2017-12-24 2018-01-07 Temozolomide + RT N Y 210025003 TEMOZOLOMIDE + RT
210030551 210037420 1.57 62 Curative (C) 2016-02-19 2016-03-07 Temozolomide + RT 02 N 210025011 TEMOZOLOMIDE + RT
210030552 210010635 1.64 51.9 null 2015-11-29 2015-12-13 Temozolomide + RT null null 210025095 TEMOZOLOMIDE + RT
210030553 210020907 1.8 60.6 Curative (C) 2015-06-03 2015-07-08 Temozolomide + RT 02 null 210025161 TEMOZOLOMIDE + RT
210030554 210010649 1.19 63.5 Adjuvant (A) 2014-04-18 2014-05-24 Temozolomide + RT N N 210025249 TEMOZOLOMIDE + RT